Our COO & Co-founder, Rebecca Stjernberg Bejhed, is eagerly anticipating a deep dive course on the FDA guidance for biological safety with experts from NAMSA.
Our goal is to be first on the US market with our ground-breaking re-connectable breakaway connector for IV therapy. We are on a mission to reshape the landscape of IV therapy and make a significant impact on the lives of patients and nurses.
